Skip to main content
Erschienen in: Tumor Biology 9/2014

01.09.2014 | Research Article

RETRACTED ARTICLE: FBXL5 targets cortactin for ubiquitination-mediated destruction to regulate gastric cancer cell migration

verfasst von: Gang Cen, Hong-Hua Ding, Bin Liu, Wei-Dong Wu

Erschienen in: Tumor Biology | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Cortactin, an actin-interacting protein, is implicated in cytoskeletal architecture and often amplified in several types of cancer including gastric adenocarcinomas. Downregulation of cortactin decreases cell migration and invasion. However, how to regulate cortactin in gastric cancer remains largely unknown. Here, we report that FBXL5 interacts with and targets cortactin for ubiquitylation and subsequent proteasomal degradation. Furthermore, we showed that FBXL5-induced cortactin degradation is mediated by extracellular regulated signal kinase (ERK). Serine phosphorylation sites mutant, cortactinS405A/S418A, prevent FBXL5-induced cortactin degradation. Moreover, CortactinS405A/S418A exhibited stronger effects in promoting gastric cancer cell migration when compared to wild-type cortactin. Taken together, our data suggested a novel molecular mechanism for the negative regulation of cortactin by FBXL5 in gastric cancer cells migration.
Literatur
1.
Zurück zum Zitat Villanueva MT. Combination therapy: Update on gastric cancer in East Asia. Nat Rev Clin Oncol. 2011;8:690.CrossRefPubMed Villanueva MT. Combination therapy: Update on gastric cancer in East Asia. Nat Rev Clin Oncol. 2011;8:690.CrossRefPubMed
2.
Zurück zum Zitat Smyth EC, Cunningham D. Gastric cancer in 2012: Defining treatment standards and novel insights into disease biology. Nat Rev Clin Oncol. 2013;10:73–4.CrossRefPubMed Smyth EC, Cunningham D. Gastric cancer in 2012: Defining treatment standards and novel insights into disease biology. Nat Rev Clin Oncol. 2013;10:73–4.CrossRefPubMed
3.
Zurück zum Zitat Yakirevich E, Resnick MB. Pathology of gastric cancer and its precursor lesions. Gastroenterol Clin N Am. 2013;42:261–84.CrossRef Yakirevich E, Resnick MB. Pathology of gastric cancer and its precursor lesions. Gastroenterol Clin N Am. 2013;42:261–84.CrossRef
4.
Zurück zum Zitat Wu H, Parsons JT. Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J Cell Biol. 1993;120:1417–26.CrossRefPubMed Wu H, Parsons JT. Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J Cell Biol. 1993;120:1417–26.CrossRefPubMed
6.
Zurück zum Zitat Huang C, Liu J, Haudenschild CC, Zhan X. The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells. J Biol Chem. 1998;273:25770–6.CrossRefPubMed Huang C, Liu J, Haudenschild CC, Zhan X. The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells. J Biol Chem. 1998;273:25770–6.CrossRefPubMed
7.
Zurück zum Zitat Zhao J, Wei J, Mialki R, Zou C, Mallampalli RK, Zhao Y. Extracellular signal-regulated kinase (erk) regulates cortactin ubiquitination and degradation in lung epithelial cells. J Biol Chem. 2012;287:19105–14.CrossRefPubMedPubMedCentral Zhao J, Wei J, Mialki R, Zou C, Mallampalli RK, Zhao Y. Extracellular signal-regulated kinase (erk) regulates cortactin ubiquitination and degradation in lung epithelial cells. J Biol Chem. 2012;287:19105–14.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Liu B, Zheng Y, Wang TD, Xu HZ, Xia L, Zhang J, et al. Proteomic identification of common scf ubiquitin ligase fbxo6-interacting glycoproteins in three kinds of cells. J Proteome Res. 2012;11:1773–81.CrossRefPubMed Liu B, Zheng Y, Wang TD, Xu HZ, Xia L, Zhang J, et al. Proteomic identification of common scf ubiquitin ligase fbxo6-interacting glycoproteins in three kinds of cells. J Proteome Res. 2012;11:1773–81.CrossRefPubMed
9.
Zurück zum Zitat Skaar JR, Pagan JK, Pagano M. Mechanisms and function of substrate recruitment by f-box proteins. Nat Rev Mol Cell Biol. 2013;14:369–81.CrossRefPubMed Skaar JR, Pagan JK, Pagano M. Mechanisms and function of substrate recruitment by f-box proteins. Nat Rev Mol Cell Biol. 2013;14:369–81.CrossRefPubMed
10.
Zurück zum Zitat Hsiang CY, Wu SL, Ho TY. Activation of activator protein 1 and extracellular signal-regulated kinases in human hepatocellular transformation. Tumour Biol J Int Soc Oncodev Biol Medic. 2004;25:313–20.CrossRef Hsiang CY, Wu SL, Ho TY. Activation of activator protein 1 and extracellular signal-regulated kinases in human hepatocellular transformation. Tumour Biol J Int Soc Oncodev Biol Medic. 2004;25:313–20.CrossRef
11.
Zurück zum Zitat Folio C, Zalacain M, Zandueta C, Ormazabal C, Sierrasesumaga L, San Julian M, et al. cortactin (cttn) overexpression in osteosarcoma correlates with advanced stage and reduced survival. Cancer Biomark Sect A Dis Markers. 2011;10:35–41.CrossRef Folio C, Zalacain M, Zandueta C, Ormazabal C, Sierrasesumaga L, San Julian M, et al. cortactin (cttn) overexpression in osteosarcoma correlates with advanced stage and reduced survival. Cancer Biomark Sect A Dis Markers. 2011;10:35–41.CrossRef
12.
Zurück zum Zitat Ambrosio EP, Rosa FE, Domingues MA, Villacis RA, Coudry Rde A, Tagliarini JV, et al. cortactin is associated with perineural invasion in the deep invasive front area of laryngeal carcinomas. Hum Pathol. 2011;42:1221–9.CrossRefPubMed Ambrosio EP, Rosa FE, Domingues MA, Villacis RA, Coudry Rde A, Tagliarini JV, et al. cortactin is associated with perineural invasion in the deep invasive front area of laryngeal carcinomas. Hum Pathol. 2011;42:1221–9.CrossRefPubMed
13.
Zurück zum Zitat Ruiz JC, Walker SD, Anderson SA, Eisenstein RS, Bruick RK. F-box and leucine-rich repeat protein 5 (fbxl5) is required for maintenance of cellular and systemic iron homeostasis. J Biol Chem. 2013;288:552–60.CrossRefPubMed Ruiz JC, Walker SD, Anderson SA, Eisenstein RS, Bruick RK. F-box and leucine-rich repeat protein 5 (fbxl5) is required for maintenance of cellular and systemic iron homeostasis. J Biol Chem. 2013;288:552–60.CrossRefPubMed
14.
Zurück zum Zitat Moroishi T, Nishiyama M, Takeda Y, Iwai K, Nakayama KI. The fbxl5-irp2 axis is integral to control of iron metabolism in vivo. Cell Metab. 2011;14:339–51.CrossRefPubMed Moroishi T, Nishiyama M, Takeda Y, Iwai K, Nakayama KI. The fbxl5-irp2 axis is integral to control of iron metabolism in vivo. Cell Metab. 2011;14:339–51.CrossRefPubMed
15.
Zurück zum Zitat Vashisht AA, Zumbrennen KB, Huang X, Powers DN, Durazo A, Sun D, et al. Control of iron homeostasis by an iron-regulated ubiquitin ligase. Science. 2009;326:718–21.CrossRefPubMedPubMedCentral Vashisht AA, Zumbrennen KB, Huang X, Powers DN, Durazo A, Sun D, et al. Control of iron homeostasis by an iron-regulated ubiquitin ligase. Science. 2009;326:718–21.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Salahudeen AA, Thompson JW, Ruiz JC, Ma HW, Kinch LN, Li Q, et al. An e3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis. Science. 2009;326:722–6.CrossRefPubMedPubMedCentral Salahudeen AA, Thompson JW, Ruiz JC, Ma HW, Kinch LN, Li Q, et al. An e3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis. Science. 2009;326:722–6.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Roskoski Jr R. Erk1/2 map kinases: Structure, function, and regulation. Pharmacolo Res Off J Ital Pharmacol Soc. 2012;66:105–43. Roskoski Jr R. Erk1/2 map kinases: Structure, function, and regulation. Pharmacolo Res Off J Ital Pharmacol Soc. 2012;66:105–43.
18.
Zurück zum Zitat Kim SK, Abdelmegeed MA, Novak RF. The mitogen-activated protein kinase kinase (mek) inhibitor pd98059 elevates primary cultured rat hepatocyte glutathione levels independent of inhibiting mek. Drug Metab Dispos Biol Fate Chem. 2006;34:683–9.CrossRefPubMed Kim SK, Abdelmegeed MA, Novak RF. The mitogen-activated protein kinase kinase (mek) inhibitor pd98059 elevates primary cultured rat hepatocyte glutathione levels independent of inhibiting mek. Drug Metab Dispos Biol Fate Chem. 2006;34:683–9.CrossRefPubMed
19.
Zurück zum Zitat Mezi S, Todi L, Orsi E, Angeloni A, Mancini P. Involvement of the src-cortactin pathway in migration induced by igf-1 and egf in human breast cancer cells. Int J Oncol. 2012;41:2128–38.PubMed Mezi S, Todi L, Orsi E, Angeloni A, Mancini P. Involvement of the src-cortactin pathway in migration induced by igf-1 and egf in human breast cancer cells. Int J Oncol. 2012;41:2128–38.PubMed
20.
Zurück zum Zitat Nakane K, Fujita Y, Terazawa R, Atsumi Y, Kato T, Nozawa Y, et al. Inhibition of cortactin and sirt1 expression attenuates migration and invasion of prostate cancer du145 cells. Int J Urol Off J Jpn Urol Assoc. 2012;19:71–9. Nakane K, Fujita Y, Terazawa R, Atsumi Y, Kato T, Nozawa Y, et al. Inhibition of cortactin and sirt1 expression attenuates migration and invasion of prostate cancer du145 cells. Int J Urol Off J Jpn Urol Assoc. 2012;19:71–9.
Metadaten
Titel
RETRACTED ARTICLE: FBXL5 targets cortactin for ubiquitination-mediated destruction to regulate gastric cancer cell migration
verfasst von
Gang Cen
Hong-Hua Ding
Bin Liu
Wei-Dong Wu
Publikationsdatum
01.09.2014
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 9/2014
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2104-9

Weitere Artikel der Ausgabe 9/2014

Tumor Biology 9/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.